Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer

2 Views
administrator
administrator
07/14/23

David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).

More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next